Get startedLog in
    Picture of Black Diamond Therapeutics logo

    BDTX — Black Diamond Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Black Diamond Therapeutics Reports Quarterly Loss Of $0.60 Per Share

    Picture of Black Diamond Therapeutics logoBlack Diamond Therapeutics
    08/11/2022 13:00
    Nov 8 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS- CASH, CASH EQUIVALENTS &
INVESTMENTS
OF $144.2 MILLION AT QUARTER END EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO Q3 2024
    * QTRLY LOSS PER SHARE $0.60
    * Q3 EARNINGS PER SHARE VIEW $-0.64 -- REFINITIV IBES DATA

Source text for Eikon:  ID: 
Further company coverage:  BDTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Black Diamond Therapeutics

    See all news